Clinical Research Directory
Browse clinical research sites, groups, and studies.
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Sponsor: National Institute of Mental Health (NIMH)
Summary
Background: About 5 million adults in the U.S. have Alzheimer s disease or another adult-onset neurodegenerative disorder. Many studies have found that inflammation in the brain contributes to these diseases. Researchers want to find a better way to measure this inflammation. Objective: To learn whether COX-1 and/or COX-2 is elevated in the brains of individuals with neurodegenerative brain disease compared to healthy volunteers. Eligibility: Adults age 18 years and older in good general health who have an adult-onset neurodegenerative dementia, such as AD, FTD, corticobasal syndrome, Huntington s disease, or MCI, ALS and healthy adult volunteers enrolled in protocols 01-M-0254 or 17-M-0181. Design: Participants will be screened with medical history, physical exam with vital signs, and lab tests. They will have a neuropsychological testing. Their heart function will be measured. Participants will have a magnetic resonance imaging (MRI) scan. The MRI scanner is a metal tube surrounded by a strong magnetic field. Participants will lie on a table that slides in and out of the tube. The machine makes noise. Participants will get earplugs. Participants will have 2 PET scans. They will be injected with the study drugs through an intravenous catheter placed in an arm vein. The PET scanner is shaped like a doughnut. Participants will lie on a bed that slides in and out of the scanner. A plastic mask will be molded to their head to keep them from moving. A thin plastic tube will be put into an artery at the wrist or elbow crease area. This will be used to draw blood during the scan. Participants will have 2-5 study visits. Participation lasts 1 week to 4 months, depending on scheduling.
Official title: Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
184
Start Date
2021-08-17
Completion Date
2030-10-03
Last Updated
2026-02-17
Healthy Volunteers
Yes
Interventions
11C-MC1
Injected IV followed by PET scanning
11C-PS13
Injected IV followed by PET scanning
18f-florbetaben
Injected IV followed by PET scanning
Locations (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, United States